Literature DB >> 21372253

Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate.

Henrik Reinhard1, Peter R Hansen, Frederik Persson, Lise Tarnow, Niels Wiinberg, Andreas Kjær, Claus L Petersen, Kaj Winther, Hans-Henrik Parving, Peter Rossing, Peter K Jacobsen.   

Abstract

BACKGROUND: Elevated plasma N-terminal (NT)-proBNP levels and coronary calcium score (CCS) not only predicts myocardial ischaemia and coronary artery stenosis but also adverse cardiovascular events and mortality in type 2 diabetic patients with an increased urinary albumin excretion rate (UAER), whereas low levels are associated with low frequency of coronary artery disease (CAD) and good prognosis. The underlying causes of poor prognosis in patients with elevated NT-proBNP are not known; thus, we investigated the role of putative asymptomatic CAD in type 2 diabetic patients with UAER >30 mg/24 h and elevated P-NT-proBNP and/or CCS.
METHODS: We identified 200 type 2 diabetic patients without known CAD and with normal creatinine levels. Patients with P-NT-proBNP >45.2 ng/L (the median P-NT-proBNP value in this cohort and in accordance with our previous findings) and/or CCS ≥ 400 were stratified as high-risk patients for CAD (n = 133) and all other patients as low-risk patients (n = 67). High-risk patients were examined by myocardial perfusion imaging (MPI; n = 109) and/or computer tomography angiography (n = 20) and/or coronary angiography (CAG; n = 86).
RESULTS: All patients received intensive mulitifactorial intervention. In 70 of 133 (53%) high-risk patients, significant CAD was demonstrated by MPI and/or CAG, corresponding to 35% (70/200) of the total cohort. Among high-risk patients, CCS but not P-NT-proBNP was paralleled by increased prevalence of significant CAD and in the 86 patients where CAG was performed, a CCS <100 had a negative predictive value for coronary artery stenosis of 94% (P = 0.04).
CONCLUSIONS: Our study revealed that >50% of asymptomatic type 2 diabetic patients with UAER >30 mg/24 h had significant CAD based on risk stratification with P-NT-proBNP and CCS. This provides some explanation to the previously reported poor prognosis in these asymptomatic patients. Optimized cardio protective treatment in these patients is warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372253     DOI: 10.1093/ndt/gfr009

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.

Authors:  Emilie H Zobel; Bernt Johan von Scholten; Henrik Reinhard; Frederik Persson; Tine W Hansen; Hans-Henrik Parving; Peter K Jacobsen; Peter Rossing
Journal:  Diabetologia       Date:  2017-07-05       Impact factor: 10.122

2.  Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.

Authors:  Bernt Johan von Scholten; Henrik Reinhard; Tine W Hansen; Jens Oellgaard; Hans-Henrik Parving; Peter K Jacobsen; Peter Rossing
Journal:  Diabetologia       Date:  2016-03-31       Impact factor: 10.122

3.  A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.

Authors:  S S Roscioni; D de Zeeuw; M E Hellemons; H Mischak; P Zürbig; S J L Bakker; R T Gansevoort; H Reinhard; F Persson; M Lajer; P Rossing; H J Lambers Heerspink
Journal:  Diabetologia       Date:  2012-10-20       Impact factor: 10.122

4.  Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria.

Authors:  Henrik Reinhard; Mads Nybo; Peter R Hansen; Niels Wiinberg; Andreas Kjær; Claus L Petersen; Kaj Winther; Hans-Henrik Parving; Lars M Rasmussen; Peter Rossing; Peter K Jacobsen
Journal:  Cardiovasc Diabetol       Date:  2011-07-29       Impact factor: 9.951

5.  NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.

Authors:  Henrik Reinhard; Niels Wiinberg; Peter R Hansen; Andreas Kjær; Claus L Petersen; Kaj Winther; Hans-Henrik Parving; Peter Rossing; Peter K Jacobsen
Journal:  Cardiovasc Diabetol       Date:  2011-08-03       Impact factor: 9.951

6.  Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate.

Authors:  Christel Joergensen; Henrik Reinhard; Anne Schmedes; Peter R Hansen; Niels Wiinberg; Claus L Petersen; Kaj Winther; Hans-Henrik Parving; Peter K Jacobsen; Peter Rossing
Journal:  Diabetes Care       Date:  2011-10-31       Impact factor: 19.112

7.  NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.

Authors:  Henrik Reinhard; Peter R Hansen; Niels Wiinberg; Andreas Kjær; Claus L Petersen; Kaj Winther; Hans-Henrik Parving; Peter Rossing; Peter K Jacobsen
Journal:  Cardiovasc Diabetol       Date:  2012-03-05       Impact factor: 9.951

8.  Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.

Authors:  Bernt Johan von Scholten; Henrik Reinhard; Tine Willum Hansen; Morten Lindhardt; Claus Leth Petersen; Niels Wiinberg; Peter Riis Hansen; Hans-Henrik Parving; Peter Karl Jacobsen; Peter Rossing
Journal:  Cardiovasc Diabetol       Date:  2015-05-21       Impact factor: 9.951

9.  Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.

Authors:  Emilie H Zobel; Bernt Johan von Scholten; Henrik Reinhard; Frederik Persson; Tom Teerlink; Tine W Hansen; Hans-Henrik Parving; Peter K Jacobsen; Peter Rossing
Journal:  Cardiovasc Diabetol       Date:  2017-07-11       Impact factor: 9.951

10.  Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients.

Authors:  Henrik Reinhard; Ellen Garde; Arnold Skimminge; Per Åkeson; Thomas Zoëga Ramsøy; Kaj Winther; Hans-Henrik Parving; Peter Rossing; Peter K Jacobsen
Journal:  Cardiovasc Diabetol       Date:  2012-10-03       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.